Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
EU first to clear AbbVie's Rinvoq for alopecia areata
1+ mon, 2+ week ago (415+ words) AbbVie's fast-growing JAK inhibitor Rinvoq has been cleared for alopecia areata in the EU, the first market for the hair loss disorder, adding to a lengthening list of approved indications for the blockbuster brand. The green light from the European…...
I tested the viral "as good as minoxidil" Mielle rosemary oil for 3 months. Here's what happened.
1+ mon, 2+ week ago (1660+ words) "I never wear my hair down because it has no volume."That's how our tester described her hair before trying Mielle Rosemary Mint Hair Oil: thinning all over, a skimpy ponytail, less body and the kind of diffuse shedding that…...
Veradermics' Oral Hair Loss Drug for Women Shows Results In Just 2 Months
1+ mon, 3+ week ago (43+ words) Veradermics Incorporated on Wednesday released topline results from an open-label Phase 2 trial evaluating its experimental VDPHL01 in women with mild-to-moderate pattern hair loss. The company said the treatment produced consistent hair growth, demonstrated an early onset of activity, and......
Veradermics Reports Positive Phase 2 Hair Loss Drug Trial Results
1+ mon, 3+ week ago (337+ words) Veradermics Incorporated announced on Wednesday positive topline results from an open-label Phase 2 clinical trial evaluating its experimental oral therapy, VDPHL01, for women experiencing mild-to-moderate pattern hair loss. As reported by Detik Finance, the biotechnology firm stated that the treatment demonstrated consistent…...
Robust growth seen with potential first hair loss pill for women: Topline data
1+ mon, 3+ week ago (74+ words) A proprietary extended-release oral minoxidil tablet induced rapid, robust and consistent hair growth in women with female pattern hair loss, according to topline results. Results from study 207 showed VDPHL01 (Veradermics) increased hair count for women who received once or twice daily…...
Veradermics keeps ‘momentum going’ as baldness drug helps women with hair loss
1+ mon, 3+ week ago (396+ words) The Phase 2 data exceeded expectations, lifting company shares as high as nearly $130 apiece and building the case for what may be the first pill specifically approved for female pattern hair loss. The results exceeded investor expectations and built on a…...
Top-five global pharma signs deal to test Kangstem’s hair follicle organoids for hair-loss drugs
1+ mon, 3+ week ago (439+ words) One of the world’s five largest pharmaceutical companies has agreed to test hair-loss drug candidates using human hair follicle organoids developed by Kangstem Biotech, the Korean company said Thursday. Kangstem did not name its partner in Thursday’s release, citing a…...
Veradermics stock jumps again on female hair loss drug win
1+ mon, 3+ week ago (506+ words) This is the second positive Phase II readout of VDPHL01, which analysts note could represent a $2bn+ market opportunity Veradermics has seen another jump in its stock price as its hair loss drug showed benefit in women with androgenetic alopecia (AGA). Patients…...
Veradermics stock jumps on encouraging data for oral hair loss option in women
1+ mon, 4+ week ago (15+ words) FirstWord PHARMA...
Veradermics reports phase 2 hair loss trial results By Investing.com
1+ mon, 4+ week ago (313+ words) Goldman Sachs flags fresh upside risks for oil as Gulf flows falter ASML, Inflation boost, Earnings roll on - What’s moving markets FREE WEBINAR: Investing.com experts unveil the top 10 ‘buy now’ picks for H2 2026 European chip stocks gain as ASML lifts…...